Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
International Journal of Oncology|October 20, 2004
Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell linesArata Tsutsumida, Jun-ichi Hamada, Mitsuhiro Tada, et al.Proceedings of the National Academy of Sciences of the United States of America|January 8, 2008
Structural basis for ligand-mediated mouse GITR activationZhaocai Zhou, Yukiko Tone, Xiaomin Song, et al.Cancer|February 22, 2002
Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomasFumihiro Hommura, Keiji Furuuchi, Koichi Yamazaki, et al.The American Journal of Pathology|November 25, 2003
Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutationsHidehisa Yamada, Keiji Furuuchi, Tetsuya Aoyama, et al.Cancer Letters|June 29, 2004
Expression of AIE-75 PDZ-domain protein induces G2/M cell cycle arrest in human colorectal adenocarcinoma SW480 cellsAtsuko Hirai, Mitsuhiro Tada, Keiji Furuuchi, et al.Immunological Reviews|August 15, 2006
FOXP3 ensembles in T-cell regulationBin Li, Arabinda Samanta, Xiaomin Song, et al.Neoplasia (New York, N.Y.)|April 8, 2025
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profilingSho Sato, Shigehiro Yagishita, Hiroshi Yoshida, et al.DNA and Cell Biology|August 17, 2004
The centrosome in normal and transformed cellsQiang Wang, Yoshihiko Hirohashi, Keiji Furuuchi, et al.Molecular Cancer Therapeutics|June 23, 2025
Antitumor Effect of Farletuzumab ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft ModelsShigehiro Yagishita, Sho Sato, Daisuke Shintani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid TumorsToshio Shimizu, Yutaka Fujiwara, Kan Yonemori, et al.Pageof 3